- Exchange: NASDAQ GS
- Sector: Health Care
- Industry: Biotech & Pharma
- Sub-Industry: Biotech
BioCryst Pharmaceuticals Inc+ Add to Watchlist
BCRX:US11.2200 USD 0.1000 0.88%
As of 14:38:28 ET on 05/28/2015.
Company Profile for BioCryst Pharmaceuticals Inc (BCRX)
BioCryst Pharmaceuticals, Inc. designs, optimizes and develops small-molecule novel pharmaceuticals that block key enzymes involved in infectious diseases, inflammatory diseases & cancer. The Company has late-stage compounds in development & continues to discover additional compounds & to progress them to meet the unmet medical needs of patients and physicians.
BioCryst Pharmaceuticals Inc
Key Executives for BioCryst Pharmaceuticals Inc (BCRX)
|Jon P StonehousePresident/CEO||Thomas R Staab II "Tom"Senior VP/CFO/Chief Acctg Ofcr|
|Lynne PowellSenior VP/Chief Commercial Ofcr||William P SheridanSenior VP/Chief Medical Ofcr|
|Yarlagadda S BabuSenior VP:Drug Discovery||Alane P BarnesVP/Secretary/General Counsel|
|Robert Bennett "Rob"VP:Investor Relations|